Preeclampsia Diagnostics Market Worth USD 2.52 Billion at 11.0% CAGR; Increasing Healthcare Expenditure to Boost Growth: Fortune Business Insights™

Key Prominent Players Covered in the Preeclampsia Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd, PerkinElmer Inc., DRG INSTRUMENTS GMBH, Thermo Fisher Scientific Inc., Diabetomics, Inc, Metabolomic Diagnostics Ltd., Sera Prognostics, Siemens Healthineers AG, Bayer AG and other key market players.

Pune, India, Jan. 21, 2021 (GLOBE NEWSWIRE) -- The global preeclampsia diagnostics market size is anticipated to gain momentum from the increasing number of pregnancies owing to the complete lockdown amid the COVID-19 pandemic. The report further states that this market size was USD 1.06 billion in 2019 and is projected to reach USD 2.52 billion by 2027, thereby exhibiting a CAGR of 11.0% during the forecast period. In 2019, North America generated USD 401.9 million in terms of preeclampsia screening market revenue. This growth is attributable to the significant healthcare expenditure and the rising usage of technologically advanced preeclampsia diagnostics kits in this region.


  • February 2019: Diabetomics announced the launch of Lumella, a rapid point-of-care test for Preeclampsia in Hydrabad.
  • February 2016: Diabetomics, Inc. announced its strategic partnership with BD to conduct a newly developed pregnancy-specific metabolic assay for the early detection of preeclampsia and gestational diabetes.

Request a Sample Copy of the Research Report:

Increasing Prevalence of Preeclampsia in Developing Nations to Boost Growth

The increasing perinatal and maternal morbidity & mortality rate is set to surge the need for the early diagnosis of preeclampsia worldwide among pregnant women. The British Charity Action on Pre-eclampsia (APEC) declared that in the U.K. every year, around 7 mothers die on account of complications related to preeclampsia and approximately 1000 babies die owing to the same cause.

The condition is majorly affecting the health of both neonates and mother, especially in the emerging countries. As per the BMC Journal, in Africa, preeclampsia affects around 10% of pregnant women annually. These factors are set to propel the preeclampsia testing market growth in the coming years.

The outbreak of the COVID-19 pandemic has caused an unprecedented demand in the healthcare industry. Presently, because of the unavailability of efficient healthcare facilities and midwives, the cases of cancelled or delayed abortions have surged rapidly. Besides, the number of coronavirus positive cases amongst pregnant women is increasing, which, in turn, is resulting in the high demand for preeclampsia diagnostics. We are providing elaborate research reports to help you better understand the effects of this pandemic on every pandemic.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

High Pregnancy Rate to Drive Growth in Asia Pacific

In 2019, North America generated USD 401.9 million in terms of preeclampsia screening market revenue. This growth is attributable to the significant healthcare expenditure and the rising usage of technologically advanced preeclampsia diagnostics kits in this region. Coupled with this, the increasing awareness programs amongst the patients and doctors regarding the severity of the disease would propel growth in this region.

Asia Pacific, on the other hand, is expected to remain in the second position after North America backed by the increasing adoption of fertility treatments, high rate of pregnancy, and the rising population.

Quick Buy -  Preeclampsia Diagnostics Market Research Report:

Fortune Business Insights™ lists out the names of all the renowned preeclampsia diagnostics providers operating in the global market. They are as follows:

  • F. Hoffmann-La Roche Ltd (Basel, Switzerland)
  • PerkinElmer Inc. (Massachusetts, United States)
  • Thermo Fisher Scientific Inc. (Massachusetts, United States)
  • Diabetomics, Inc. (Massachusetts, United States)
  • Metabolomic Diagnostics Ltd. (Munster, Ireland)
  • Sera Prognostics (UT, United States)
  • Siemens Healthineers AG (Erlangen, Germany)
  • Bayer AG (Leverkusen, Germany)
  • Others

Have Any Query? Ask Our Experts:

Market Segmentations:

By Test Type

•              Blood Tests

•              Urine Analysis

By Product Type

•              Instruments

•              Consumables

By End-user

•              Hospitals

•              Specialty Clinics

•              Diagnostic Centers

•              Others

By Region

•              North America (the U.S. and Canada)

•              Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

•              Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)

•              Latin America (Brazil, Mexico, and the Rest of Latin America)

•              Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)

Get your Customized Research Report:


  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.

Have a Look at Related Reports:

mHealth Market Share & Industry Analysis, By Category (By Apps {Disease & Treatment Management, Wellness Management}, By Wearable {Body & Temperature Monitors, Glucose Monitors}) By Services Type (Monitoring Services, Diagnostic Services, Treatment Services) By Service Provider (mHealth App Companies, Hospitals, Health Insurance) and Regional Forecast, 2019-2026

mHealth Apps Market Share & Industry Analysis, By App Type (Disease & Treatment Management, Wellness Management, Others), By Application (Monitoring Services, Fitness Solutions, Diagnostic Services, Treatment Services, Others), By Operating System Type (Google Play Store, Apple App Store, Others) and Regional Forecast, 2019-2026

Surgical Tables Market Share & Industry Analysis, By Product Type (General Surgery Tables, Orthopedic Tables, and Imaging Tables), By Type (Powered, Non-powered), By End User (Hospitals & ASC’s, and Specialty Clinics & Trauma Centers) and Regional Forecast, 2019-2026

Sports Medicine Market Share & Industry Analysis, By Device Type (Surgery Devices, Bone Reconstruction Devices, Body Support Devices, Others), By Application (Knee, Head & Neck, Shoulder, Ankle & Foot, Wrist & Elbow, Others) By End User (Hospitals, Specialty Clinics), and Regional Forecast, 2019-2026

Mobility Devices Market Share & Industry Analysis, By Product (Wheelchairs, Mobility Scooters, Walking Aids, and Others); By End-user (Personal Users and Institutional Users); and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: